1. Home
  2. CCG vs PYPD Comparison

CCG vs PYPD Comparison

Compare CCG & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CCG

Cheche Group Inc.

HOLD

Current Price

$0.78

Market Cap

69.5M

Sector

N/A

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.30

Market Cap

76.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCG
PYPD
Founded
2014
2008
Country
China
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.5M
76.4M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
CCG
PYPD
Price
$0.78
$4.30
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$350.00
$12.00
AVG Volume (30 Days)
90.5K
44.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$15.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$2.30
52 Week High
$1.54
$5.12

Technical Indicators

Market Signals
Indicator
CCG
PYPD
Relative Strength Index (RSI) 41.93 45.08
Support Level $0.73 $4.26
Resistance Level $0.83 $5.05
Average True Range (ATR) 0.04 0.23
MACD 0.00 -0.04
Stochastic Oscillator 44.98 30.88

Price Performance

Historical Comparison
CCG
PYPD

About CCG Cheche Group Inc.

Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: